Echo Therapeutics (ECTE) Posts Wider than Expected Q2 Loss of 8c/Share

Article Stock Quotes (1) Comments (0)

Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.9 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
• Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?